These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16920044)

  • 1. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH; Haramura G; Bagoly Z; Muszbek L
    Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.
    Undas A; Brzezinska-Kolarz B; Brummel-Ziedins K; Musial J; Szczeklik A; Mann KG
    J Thromb Haemost; 2005 Sep; 3(9):2015-21. PubMed ID: 16102108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.
    Ariëns RA; Philippou H; Nagaswami C; Weisel JW; Lane DA; Grant PJ
    Blood; 2000 Aug; 96(3):988-95. PubMed ID: 10910914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
    Balogh I; Szôke G; Kárpáti L; Wartiovaara U; Katona E; Komáromi I; Haramura G; Pfliegler G; Mikkola H; Muszbek L
    Blood; 2000 Oct; 96(7):2479-86. PubMed ID: 11001900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
    Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
    Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Val34Leu and Val35Leu polymorphism on the enzyme activity of the coagulation factor XIII-A.
    Lee IH; Chung SI; Lee SY
    Exp Mol Med; 2002 Nov; 34(5):385-90. PubMed ID: 12526104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A.
    Wartiovaara U; Mikkola H; Szôke G; Haramura G; Kárpáti L; Balogh I; Lassila R; Muszbek L; Palotie A
    Thromb Haemost; 2000 Oct; 84(4):595-600. PubMed ID: 11057856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
    Shemirani AH; Antalfi B; Pongrácz E; Mezei ZA; Bereczky Z; Csiki Z
    Blood Coagul Fibrinolysis; 2014 Jun; 25(4):364-8. PubMed ID: 24686102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXIII polymorphisms, fibrin clot structure and thrombotic risk.
    Kobbervig C; Williams E
    Biophys Chem; 2004 Dec; 112(2-3):223-8. PubMed ID: 15572253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin stabilization (factor XIII), fibrin structure and thrombosis.
    Bereczky Z; Katona E; Muszbek L
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):430-7. PubMed ID: 15692256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
    Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
    J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII expression within aortic valves and its plasma activity in patients with aortic stenosis: association with severity of disease.
    Kapusta P; Wypasek E; Natorska J; Grudzien G; Sobczyk D; Sadowski J; Undas A
    Thromb Haemost; 2012 Dec; 108(6):1172-9. PubMed ID: 23052999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke.
    Antalfi B; Pongrácz E; Csiki Z; Mezei ZA; Shemirani AH
    Int J Lab Hematol; 2013 Feb; 35(1):88-91. PubMed ID: 22909010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.